Technology Development Board

Global Automotive ADAS and Autonomous Vehicles Market Report 2023: Trends and Analysis by Technology, Companies and Forecasts to 2028 Featuring Audi, BMW, Mercedes Benx and Honda

Retrieved on:

Wednesday, November 29, 2023

Intelligence, Marketing, COVID-19, Technology Development Board, Patent analysis, Growth, ADAS, Patent, Retail

DUBLIN, Nov. 29, 2023 /PRNewswire/ -- The "Automotive ADAS and Autonomous Vehicles Market Trends and Analysis by Technology, Companies and Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points:

DUBLIN, Nov. 29, 2023 /PRNewswire/ -- The "Automotive ADAS and Autonomous Vehicles Market Trends and Analysis by Technology, Companies and Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
The global autonomous and ADAS-enabled vehicle market is estimated at 516.3 mn units in 2023, recording a substantial annual growth of 13.7%.
Over the forecast period, the sector is expected to record a CAGR of 7.0% to reach 723.9 mn units by 2028.
Sector Forecast: Provides deep-dive analysis of global market covering volume growth during 2018-2028, and spot estimates for 2023 and 2028.

Digital Oscilloscopes and Extension-Based Instruments Drive Growth, With Digital Oscilloscopes Projected at a CAGR of 8.4% and Extension-Based T&M Instruments at 12.4% - ResearchAndMarkets.com

Retrieved on:

Wednesday, October 18, 2023

Technology, Hardware, Internet of things, Innovation, Technology Development Board, Measurement, High performance organization, Medical device, Video game

Product Innovations & Technology Developments: Spearheading Growth in Oscilloscopes Market

Key Points:

Product Innovations & Technology Developments: Spearheading Growth in Oscilloscopes Market
Extension Based T&M Instruments Market: A Review
Global PXI Test and Measurement Equipment Market Share Breakdown by Product Segment: 2022
Cost-Effective and High Performance Instruments: Essential for Manufacturing Applications
Global Number of IoT Connected Devices (In Billion) for the Years 2016, 2018, 2020, 2022 & 2025
Opportunity Indicator: Global Spending (In US$ Billion) on IoT for the Years 2019, 2020, 2021, 2022 & 2024

Cyclerion Announces Definitive Agreement for Zagociguat and CY3018

Retrieved on:

Thursday, May 11, 2023

LLP, MELAS, CYCN, Stifel, Technology Development Board, INVU (song), Venrock, CNS, Patient, Therapy, Security (finance), NewCo

CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) announced today that it has signed a definitive agreement with a new private company (“NewCo”) to sell two of its sGC stimulator assets in exchange for cash and equity ownership. Investors in NewCo have agreed to invest $81M to develop zagociguat (previously CY6463) to treat MELAS* and other diseases associated with mitochondrial dysfunction and advance CY3018.

Key Points:

Investors in NewCo have agreed to invest $81M to develop zagociguat (previously CY6463) to treat MELAS* and other diseases associated with mitochondrial dysfunction and advance CY3018.
Each of the current Cyclerion investors who are participating in the NewCo capitalization have agreed to vote their Cyclerion shares in favor of the transaction.
Following the closing, NewCo will be solely responsible for all activities and expenses related to developing and commercializing zagociguat and CY3018.
Signing of the definitive agreement triggered the previously announced $5M equity investment by CEO Peter Hecht.

Pearl Health releases Top 50 Value-Based Care Thinkers of 2023

Retrieved on:

Wednesday, May 10, 2023

NEW YORK, May 10, 2023 /PRNewswire/ -- Pearl Health today released its second annual Top 50 Value-Based Care Thinkers list, which recognizes healthcare providers, policy makers, academics, and thinkers across disciplines who are leading the healthcare system's transition to value-based care.

Key Points:

NEW YORK, May 10, 2023 /PRNewswire/ -- Pearl Health today released its second annual Top 50 Value-Based Care Thinkers list, which recognizes healthcare providers, policy makers, academics, and thinkers across disciplines who are leading the healthcare system's transition to value-based care.
"We're proud to honor the VBC leaders pushing the boundaries of our thinking," said Michael Kopko, CEO of Pearl Health.
"We are experiencing a critical moment for healthcare sustainability and access," said Michael Kopko, Co-Founder and CEO of Pearl Health.
Read more insights in Pearl Health's Top 50 Value-Based Care Thinkers of 2023: pearlhealth.com/top50vbc

Dividend News Update: BOTS Board Approves Dividend; BOTS’ First Publication Reaches Number One in Five Categories on Amazon’s eBook Store; BOTS Reconsiders Developing AI Assistant Based on Scott Adams

Retrieved on:

Tuesday, March 21, 2023

Crypto, Bitcoin, Blockchain, Ebook, Black History Month, BOTS, Technology Development Board, BLM, Entrepreneurship, The Company, SAN, Economic development, OTC, FINRA, Affirmative action, News, Cryptocurrency, Kindle, Amazon

The rate of distribution which the board has approved is based on 1 $BULT for each 6.72 $BTZI held on that record date.

Key Points:

The rate of distribution which the board has approved is based on 1 $BULT for each 6.72 $BTZI held on that record date.
A new eBook titled "The Coming Age of Equity Currencies: Crypto Shares Will Change The World Forever" has been released on Amazon.
The eBook, authored by BOTS, Inc, delves into the potential of equity currencies as a disruptive force in the financial industry.
BOTS, Inc. started its publishing venture in the financial sector on March 12, 2023 upon publication of this e-Book.

University of Miami, The Miami Project to Cure Paralysis & Ulevo Health: Building an Alliance for the Future

Retrieved on:

Wednesday, February 1, 2023

COLUMBUS, Ohio, Feb. 1, 2023 /PRNewswire-PRWeb/ -- Ikove Venture Partners announced today that they have licensed certain technology from the University of Miami and The Miami Project to Cure Paralysis, to launch Ulevo Health, http://www.ulevohealth.com, a provider of medical devices which detect and stop debilitating muscle spasms due to neurological disease, paralysis, spinal injury and chronic cramping of any kind. Ulevo Health offers a wearable device that detects muscle spasms and produces a corrective stimulation as needed to immediately arrest the spasm and associated discomfort.

Key Points:

Ulevo Health offers a wearable device that detects muscle spasms and produces a corrective stimulation as needed to immediately arrest the spasm and associated discomfort.
"We are extremely pleased to have licensed the technology from the University of Miami and The Miami Project and look forward to a long and a mutually beneficial future of continued technology development," said Ikove Venture's Co-Founder, Flavio Lobato, a University of Miami alumnus.
"For me personally, to be back in Miami and to be able to work with technology that was developed at the University of Miami is truly an honor," he continued.
"Ulevo Health's technology will dramatically change the landscape of spasm detection, treatment, and relief," said Jack Karabees, Ulevo Health's Co-Founder and CEO.

Burns & Levinson Partner Bryan Natale Named to Northeast Turnaround Management Association's Board of Directors; Partner Scott Moskol Completes Tenure as TMA Northeast President

Retrieved on:

Monday, January 9, 2023

Software, Suffolk University Law School, Corporate group, Association for Corporate Growth, TMA, Boston College, Burns, Technology Development Board, Young professional, Marketing, Financial services

BOSTON, Jan. 9, 2023 /PRNewswire/ -- Burns & Levinson partner Bryan Natale has been named to the Board of Directors of the Turnaround Management Association (TMA), Northeast Chapter effective January 1, 2023.

Key Points:

BOSTON, Jan. 9, 2023 /PRNewswire/ -- Burns & Levinson partner Bryan Natale has been named to the Board of Directors of the Turnaround Management Association (TMA), Northeast Chapter effective January 1, 2023.
He replaces Scott Moskol on the Board, who completed his year-long tenure as President and member of the Board of the TMA Northeast Chapter at the end of 2022.
As a member of the Board of Directors, Natale will guide the organization's mission to help businesses that are navigating critical turning points and transitions get to the next level.
He has been involved in TMA for over 5 years, and most recently served as co-chair of the organization's Next Gen Committee.

OneD Battery Sciences Appoints GM Ventures and Volta Energy Technologies Investors to Its Board of Directors

Retrieved on:

Wednesday, October 12, 2022

PALO ALTO, Calif., Oct. 12, 2022 /PRNewswire/ -- OneD Battery Sciences (OneD), a leader in electric vehicle (EV) battery technology, has appointed: Zander Arkin, Chief Investment Officer, Volta Energy Technologies (board member); James Frith, Principal, Volta Energy Technologies (board observer); and John Du, Partner, GM Ventures (board observer) to its board.

Key Points:

PALO ALTO, Calif., Oct. 12, 2022 /PRNewswire/ -- OneD Battery Sciences (OneD), a leader in electric vehicle (EV) battery technology, has appointed: Zander Arkin, Chief Investment Officer, Volta Energy Technologies (board member); James Frith, Principal, Volta Energy Technologies (board observer); and John Du, Partner, GM Ventures (board observer) to its board.
"Volta is very impressed with both the competitive performance of OneD's SINANODE material and the economics of their production process.
Volta is excited to support the OneD team as they pursue the next phase of commercialization and manufacturing scale-up," said Zander Arkin, Chief Investment Officer at Volta.
In 2013, OneD Battery Sciences acquired Nanosys' nanowire technologies (SINANODE) and its Palo Alto R&D activities.

Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies

Retrieved on:

Tuesday, May 3, 2022

Technology, Research, Medical Devices, Other Technology, Biotechnology, Health, Pharmaceutical, Other Science, Science, Biotechnology, Toxicity, Chemistry, EUR, Nanotechnology, Economy, Partner, Climate, CEO, Technology, Land, Federal Ministry for Economic Affairs and Energy, Health Beauty Life, Carbon, DVM, Twitter, Sustainability, EVP, Investment, Patient, Partnership, Program, Industry, List of life sciences, Government, LinkedIn, Technology Development Board, General partnership, Board of directors, Control, Fraunhofer Society, Federal Ministry of Science and Technology, CMS, Neurology, MBA, Growth, USD, Board, ADC, Lists of publishing companies, Nutrition, Doctor of Philosophy, CHF, Therapy, Andera-ye Olya, Science, Evotec, Blue economy, Fine chemical, Financial services, Security (finance), Rida al-Tubuly, IPO, MD, Aquaculture

Tubulis today announced the successful completion of a 60 million (USD $63 million) Series B financing led by Andera Partners with participation from new investors Evotec and Fund+.

Key Points:

Tubulis today announced the successful completion of a 60 million (USD $63 million) Series B financing led by Andera Partners with participation from new investors Evotec and Fund+.
With its unique toolkit of proprietary technologies and its pipeline of differentiated ADC candidates, Tubulis holds a compelling position in the ADC field, stated Andera Partners Sofia Ioannidou, PhD.
Tubulis capability of creating a pipeline of antibody-drug conjugates is based on a diverse range of targeting molecules, novel payloads and proprietary conjugation technologies.
Baker McKenzie (Julia Braun) served as counsel for new Series B investors and CMS (Stefan-Ulrich Mller) for Tubulis.

George H. Kirby Named as Chief Executive Officer of RS Technologies

Retrieved on:

Monday, November 1, 2021

TILBURY, ON and CALGARY, AB, Nov. 1, 2021 /PRNewswire/ - The Board of Directors of RS Technologies Inc. ("RS" or the "Company"), a leading global provider of composite utility poles, today announced that George H. Kirby has been named as Chief Executive Officer of the Company, effective November 1st, 2021.

Key Points:

TILBURY, ON and CALGARY, AB, Nov. 1, 2021 /PRNewswire/ - The Board of Directors of RS Technologies Inc. ("RS" or the "Company"), a leading global provider of composite utility poles, today announced that George H. Kirby has been named as Chief Executive Officer of the Company, effective November 1st, 2021.
George Kirby, an aerospace engineer by education, studied composite structures and applied this knowledge throughout his career at GE Power, AMSC, SAIC and AECOM.
Mr. Kirby, a successful public company CEO, has over 20 years of applicable experience commercializing and deploying disruptive technology.
RS Technologies' growth has been impressive with increased production capacity coming online early in 2022 at the new St. George, Utah plant to meet surging demand.